BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10926798)

  • 1. Effect of different treatment modalities on the prognosis of stage IV epithelial ovarian cancer: analysis of the SEER database.
    Zhang S; Zhang H; Jia N; Suo S; Guo J
    BMC Womens Health; 2024 Jun; 24(1):345. PubMed ID: 38877551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neglected Anatomical Areas in Ovarian Cancer: Significance for Optimal Debulking Surgery.
    Kostov S; Selçuk I; Watrowski R; Dineva S; Kornovski Y; Slavchev S; Ivanova Y; Yordanov A
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of liver metastases in patients with epithelial ovarian cancer.
    Deng H; Zhu HL; Li Y; Wang Y; Wu Y; Cui H; Wang JL; Li XP
    Chin Med J (Engl); 2021 Jan; 134(10):1236-1238. PubMed ID: 33410622
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters.
    Xiao Y; Linghu H
    Cancer Control; 2023; 30():10732748231159778. PubMed ID: 36815671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Population-Based Study on Liver Metastases in Women With Newly Diagnosed Ovarian Cancer.
    Zhao H; Xu F; Li J; Ni M; Wu X
    Front Oncol; 2020; 10():571671. PubMed ID: 33102229
    [No Abstract]   [Full Text] [Related]  

  • 6. Video-assisted thoracic surgery in the primary management of advanced ovarian carcinoma with moderate to large pleural effusions: A Memorial Sloan Kettering Cancer Center Team Ovary Study.
    Boerner T; Filippova OT; Chi AJ; Iasonos A; Zhou QC; Long Roche K; Zivanovic O; Park BJ; Huang J; Jones DR; Abu-Rustum NR; Gardner G; Sonoda Y; Chi DS
    Gynecol Oncol; 2020 Oct; 159(1):66-71. PubMed ID: 32792282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival.
    Dabi Y; Huchon C; Ouldamer L; Bendifallah S; Collinet P; Bricou A; Daraï E; Ballester M; Lavoue V; Haddad B; Touboul C;
    J Transl Med; 2020 Mar; 18(1):134. PubMed ID: 32293460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Pursuit of Optimal Cytoreduction in Ovarian Cancer Patients: The Role of Surgery and Surgeon.
    Shashikant L; Kesterson Joshua P
    J Obstet Gynaecol India; 2009; 59(3):209-216. PubMed ID: 27885314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review.
    Hacker NF; Rao A
    Gynecol Oncol Res Pract; 2016; 3():7. PubMed ID: 27330821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative [F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer.
    Chung HH; Kwon HW; Kang KW; Kim JW; Park NH; Song YS; Kang SB
    J Gynecol Oncol; 2012 Jan; 23(1):28-34. PubMed ID: 22355464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic resection for metachronous metastases from ovarian carcinoma.
    Bosquet JG; Merideth MA; Podratz KC; Nagorney DM
    HPB (Oxford); 2006; 8(2):93-6. PubMed ID: 18333253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical therapy for testicular cancer metastatic to the liver.
    Maluccio M; Einhorn LH; Goulet RJ
    HPB (Oxford); 2007; 9(3):199-200. PubMed ID: 18333222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interval debulking surgery in ovarian cancer.
    van der Burg ME; Vergote I;
    Curr Oncol Rep; 2003 Nov; 5(6):473-81. PubMed ID: 14521806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced ovarian cancer.
    van der Burg ME
    Curr Treat Options Oncol; 2001 Apr; 2(2):109-18. PubMed ID: 12057129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases.
    Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM
    Gynecol Oncol; 2000 Aug; 78(2):171-5. PubMed ID: 10926798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?
    Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM
    Gynecol Oncol; 2000 Aug; 78(2):176-80. PubMed ID: 10926799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial ovarian carcinoma: principles of primary surgery.
    Hoskins WJ
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S91-6. PubMed ID: 7835815
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.